Belimumab in Autoimmune Hepatitis

Clinical trial NCT06381453 · RECRUITING

Trial details

NCT number: NCT06381453
Sponsor: University Health Network, Toronto
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Autoimmune Hepatitis

Start date: 2024-12-11
Primary completion: 2028-04-30
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.